Recurring revenue
SaaS Subscriptions
Module-based monthly/annual subscriptions. Clinics add modules as they grow; net revenue retention rises naturally.
Investor Relations
We're building the digital infrastructure of medical manufacturing
Orthotics and prosthetics is one of the last corners of healthcare that digitalization has reached. With its vertically integrated platform of software, hardware and materials, Clonify Labs aims to become the operating system of this transformation.
Market Opportunity
A large, growing and not-yet-digital market
The O&P market has a demographically guaranteed demand curve: aging populations, diabetes-related amputations and pediatric cases grow demand every year. Yet the production side still relies on manual labour — exactly the kind of inefficiency software transforms best.
* Market figures are approximate values compiled from public industry reports; detailed sources are shared in the investor deck.
Business Model
A four-layer revenue architecture that feeds itself
Hardware connects the clinic to the ecosystem, SaaS subscriptions establish recurring revenue, and every production run generates materials revenue. Each layer strengthens the sale of the others, continuously growing revenue per clinic.
Ecosystem lock-in
Hardware bundle
We recommend validated third-party scanners and printers and pair them with the software at setup. We do not manufacture devices under the Clonify brand.
Consumables revenue
Material Supply
Continuous supply of certified medical resins and filaments. Every production run generates recurring consumables revenue.
Transaction revenue
Manufacturing-as-a-Service
Per-order production through partner manufacturing centers for clinics without their own printers.
So Far
A working product, not a vision
A working multi-module product exists on desktop. Cranial is the most mature line. Multi-clinic published metrics and ISO 13485 are not in place yet — investment is to build that evidence and commercialization layer.
- Cranial, socket and splint design are active; AFO, insoles and scoliosis are in development
- No multi-clinic published metrics yet — protocol is open
- Technology startup based at Ankara Cyberpark
- Desktop CAD + web operations panel; scanner/printer bundle
Roadmap
Scaling plan
2024
Founding
Clonify Labs was founded at Ankara Cyberpark with a vision of digital transformation in O&P.
2026
First clinical validation
The cranial helmet module was validated on real patient cases in pilot clinics; the scan, measure and design flow was tested in a clinical setting. The multi-clinic measurement protocol is still running — the numbers will be published on the evidence page once it completes.
2027
General availability (GA)
The cranial helmet, prosthetic socket and hand splint lines are already in use with clinics in early access today. In 2027 the desktop CAD app and the web operations panel reach general availability as a full commercial release. Hardware is a recommended third-party bundle, not our own manufacture.
2028
Scale-up
Clinic network and measured evidence in Turkey. Scoliosis opens only as co-development with a clinical partner — not as a finished launch.
2030
Global expansion
Expansion into MENA, Europe and beyond with multilingual, regulation-compliant versions of the platform.
Be part of this transformation
Contact us for the detailed investor deck, financial projections and clinical validation data.
muammer@clonifylabs.com